Page last updated: 2024-09-03

indatraline and Parkinson Disease

indatraline has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alarcón-Aris, D; Artigas, F; Bortolozzi, A; Campa, L; Cóppola-Segovia, V; Miquel-Rio, L; Montefeltro, A; Pavia-Collado, R; Paz, V; Revilla, R; Rodríguez-Aller, R; Ruiz-Bronchal, E; Torres-López, M	1

Other Studies

1 other study(ies) available for indatraline and Parkinson Disease

Article	Year
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30PA53Tα-Synuclein Transgenic Mice. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Glycoconjugates; Humans; Indans; Injections, Intraventricular; Locus Coeruleus; Male; Mesencephalon; Methylamines; Mice; Mice, Transgenic; Norepinephrine; Oligonucleotides, Antisense; Parkinson Disease; Pars Compacta; Point Mutation; Synaptic Transmission	2021

Article

Year

Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.

International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6

Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Glycoconjugates; Humans; Indans; Injections, Intraventricular; Locus Coeruleus; Male; Mesencephalon; Methylamines; Mice; Mice, Transgenic; Norepinephrine; Oligonucleotides, Antisense; Parkinson Disease; Pars Compacta; Point Mutation; Synaptic Transmission

2021